OUR SOLUTION:
Allergen-Free Peanuts

IngateyGen’s Solution is to remove the allergens from the source and produce a peanut substantially equivalent to conventional peanut in nutrition and yield in the field. We have established a two-phase commercialization strategy:

During Phase 1: We used RNAi technology to produce a GMO peanut reduced in allergen content.

During Phase 2: We are now using CRISPR to produce a Non-GMO Allergen-Free-Peanut.

OUR PILOT STUDIES:
Success Using RNAi

IngateyGen performed a pilot study using RNAi technology and performed 3 years of field trials. Analysis by an independent lab show the following success:

Major allergens Ara h 1 and Ara h 2 were significantly reduced and/or eliminated.